Seeking Alpha

Alkermes (ALKS) releases positive results from a clinical study of a depression disorder...

Alkermes (ALKS) releases positive results from a clinical study of a depression disorder treatment. The firm says ALKS 5461 significantly reduced the severity of depression in patients treated with the drug during a 7-day period.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector